Nuclear imaging of inflammation: Homing-associated molecules as targets

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-7

  Autio, Anu ^a   Jalkanen, Sirpa ^b   Roivainen, Anne ^a,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

In vivo imaging; Inflammation; Positron emission tomography; Vascular adhesion protein 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; INTERCELLULAR ADHESION MOLECULE 1; IODINE 123; PADGEM PROTEIN; SELECTIN; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN RECEPTOR;

BINDING SITE; CELL SURFACE; HUMAN; IMAGE QUALITY; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTE MIGRATION; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 84875316209     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-1     Document Type: Review

References (49)

1. Boerman OC, Rennen H, Oyen WJ, Corstens FH: Radiopharmaceuticals to image infection and inflammation. Semi Nucl Med 2001, 31:286-295
2. Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ: Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010, 51:1937-1949.
3. Rahmim A, Zaidi H: PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun 2008, 29:193-207.
4. Love C, Tomas MB, Tronco GG, Palestro CJ: FDG PET of infection and inflammation. Radiographics 2005, 25:1357-1368.
5. Vos FJ, Bleeker-Rovers CP, Corstens FH, Kullberg BJ, Oyen WJ: FDG-PET for imaging of non-osseous infection and inflammation. QJ Nucl Med Mol Imaging 2006, 50:121-130.
6. Keelan ET, Harrison AA, Chapman PT, Binns RM, Peters AM, Haskard DO: Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nuc/Med 1994, 35:276-281
7. Chapman PT, Jamar F, Harrison AA, Schofield JB, Peters AM, Binns RM, Haskard DO: Characterization of E-selectin expression, leucocyte traffic and clinical sequelae in urate crystal-induced inflammation: an insight into gout. BrJ Rheumatol 1996, 35:323-334
8. Chapman PT, Jamar F, Keelan ET, Peters AM, Haskard DO: Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996, 39:1371-1375.
9. Bhatti M, Chapman P, Peters M, Haskard D, Hodgson HJ: Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998, 43:40-47.
10. Jamar F, Houssiau FA, Devogelaer JP, Chapman PT, Haskard DO, Beaujean V, Beckers C, Manicourt DH, Peters AM: Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002,4153-61.
11. 99mTc-radiolabeled E-selectin-binding peptide. Arthritis Rheum 1999,42:641-649.
12. Ji S, Fang W, Zhu M, Bai X, Wang C, Ruan C: Detection of pulmonary embolism with 99mTc-labeled F(ab)2 fragment of anti-P-selectin monoclonal antibody in dogs. Tohoku J Exp Med 2011, 223:9-15
13. 23lodine-labelled anti-VCAM-1 antibody scintigraphy in the assessment of experimental colitis. Eur J Gastroenterol Hepatol 2001, 13:31-38
14. Broisat A, Riou LM, Ardisson V, Boturyn D, Dumy P, Fagret D, Ghezzi C: Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p. Eur J Nucl Med Mol Imaging 2007, 34:830-840.
15. 18F-4Vfor PET-CT imaging of VCAM-1 expression in atherosclerosis. JAGG Cardiovasc Imaging 2009, 2:1213-1222.
16. Weiner RE, Sasso DE, Gionfriddo MA, Syrbu SI, Smilowitz HM, Vento J, Thrall RS: Early detection of bleomycin-induced lung injury in rat using indium-111 -labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 1998,39:723-728.
17. ,8F-galacto-RGD. J Nucl Med 2005, 46:184-189.
18. Cao Q, Cai W, Li ZB, Chen K, He L, Li HC, Hui M, Chen X: PET imaging of acute and chronic inflammation in living mice, Eur J Nucl Med Mol Imaging 2007, 34:1832-1842.
19. 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Grc Cardiovasc Imaging 2009, 2:331-338
20. 68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice. Eur J Nucl Med Mol Imaging 2009, 36:2058-2067.
21. Cai W, Gambhir SS, Chen X: Multimodality tumor imaging targeting integrin alphavbeta3. Biotechniques 2005, 39(Suppl):14-25
22. Haubner R: Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? Eur J Nucl Med Mol Imaging 2006,33(Suppl):54-63.
23. Beer AJ, Schwaiger M: Imaging of integrin alphavbeta3 expression. Cancer Metastasis Rev 2008, 27:631-644.
24. Salmi M, Jalkanen S: VAP-1: an adhesin and an enzyme. Trends Immunol 2001,22:211-216.
25. Salmi M, Jalkanen S: Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med 1996, 183:569-579
26. Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S: Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood 2009, 114:5385-5392.
27. Airenne TT, Nymalm Y, Kidron H, Smith DJ, Pihlavisto M, Salmi M, Jalkanen S, Johnson MS, Salminen TA: Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications. Protein Sc 2005,14:1964-1974
28. Salmi M, Jalkanen S: Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. FEBS Lett 2011,585:1543-1550.
29. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S: A cell surface amine oxidase directly controls lymphocyte migration. Immunity 2001, 14:265-276.
30. Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S: Origins of serum semicarbazide-sensitive amine oxidase. Grc Res 2004, 95:50-57
31. Jaakkola K, Nikula T, Holopainen R, Vahasilta T, Matikainen MT, Laukkanen ML, Huupponen R, Halkola L, Nieminen L, Hiltunen J, Parviainen S, Clark MR, Knuuti J, Savunen T, Kaapa P, Voipio-Pulkki LM, Jalkanen S: In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol 2000,157:463-471.
32. Kurkijarvi R, Jalkanen S, Isoniemi H, Salmi M: Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection, Eur J Immunol 2001, 31:2876-2884
33. Martelius T, Salaspuro V, Salmi M, Krogerus L, Hockerstedt K, Jalkanen S, Lautenschlager I: Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection. Am J Pathol 2004, 165:1993-2001.
34. Xu HL, Salter-Cid L, Linnik MD, Wang EY, Paisansathan C, Pelligrino DA: Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia. J Pharmacol Exp Ther 2006, 317:19-29.
35. O'Rourke AM, Wang EY, Salter-Cid L, Huang L, Miller A, Podar E, Gao HF, Jones DS, Linnik MD: Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J Neural Transm 2007, 114:845-849
36. Stolen CM, Marttila-lchihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hanninen A, Jalkanen S, Salmi M: Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 2005, 22:105-115.
37. Lankinen P, Makinen TJ, Poyhonen TA, Virsu P, Salomaki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A: (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones, Eur J Nucl Med Mol Imaging 2008, 35:352-364
38. 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: A potential PET imaging agent for diagnosing osteomyelitis. Nucl Med Biol 2009,36:631-641.
39. 18F]-FDG. EurJ Nucl Med Mol Imaging 2010, 37:1918-1925.
40. 68Ga]-DOTAVAP-P1 peptide improves PET imaging of inflammation. EJNMMI Research 2011, 1:10.
41. Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-lchihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S: Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood 2011,118:3725-3733
42. Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, Salmi M: A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress, Eur J Immunol 2004, 34:2276-2285.
43. Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH: Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002, 169:983-992.
44. 68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats-comparison with FDG. Mol Imaging Biol 2010, 12:259-268.
45. Salmi M, Jalkanen S: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992, 257:1407-1409
46. Salmi M, Kalimo K, Jalkanen S: Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 1993, 178:2255-2260.
47. Salmi M, Rajala P, Jalkanen S: Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest 1997, 99:2165-2172.
48. Jaakkola K, Jalkanen S, Kaunismaki K, Vanttinen E, Saukko P, Alanen K, Kallajoki M, Voipio-Pulkki LM, Salmi M: Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol 2000, 36:122-129
49. Biotie Therapies, http://www.biotie.com/en/product_and_development/inflammation/vap1_antibody. Accessed 23 August 2012.